Sign in

    Mike Zaremski

    Managing Director and Senior Equity Research Analyst at BMO Capital Markets

    Mike Zaremski is a Managing Director and Senior Equity Research Analyst at BMO Capital Markets, specializing in insurance sector equities—particularly property & casualty, life, and mortgage insurance companies. He actively covers companies such as Selective Insurance Group, Brown & Brown, Kinsale Capital Group, and Horace Mann Educators, and has established a strong track record with an analyst success rate near 64% and an average return of approximately 7%, placing him among the top 550 analysts out of nearly 5,000. Zaremski began his equity research career at Credit Suisse in 2007, later spending several years on the buyside at Balyasny Asset Management, then returning to Credit Suisse and joining Wolfe Research as Director before being appointed Managing Director at BMO in June 2022. He holds FINRA registrations and is recognized as a highly respected specialist in insurance equities, regularly contributing impactful insights for institutional investors.

    Mike Zaremski's questions to HANOVER INSURANCE GROUP (THG) leadership

    Mike Zaremski's questions to HANOVER INSURANCE GROUP (THG) leadership • Q2 2025

    Question

    Mike Zaremski of BMO Capital Markets asked for details on the Q3 catastrophe load guidance, the competitive landscape in commercial lines, and the outlook for net investment income, including current reinvestment rates.

    Answer

    EVP & CFO Jeffrey Farber confirmed the 6.8% Q3 cat load, attributing improvements to actions in both personal and commercial lines. President & CEO John Roche and EVP & COO Richard Lavey stated that while property pricing is competitive, liability lines are firming, and their diversified portfolio provides resilience. Farber added that the reinvestment rate is around 5% or the low 5s.

    Ask Fintool Equity Research AI

    Mike Zaremski's questions to ALLSTATE (ALL) leadership

    Mike Zaremski's questions to ALLSTATE (ALL) leadership • Q1 2025

    Question

    Mike Zaremski asked why Allstate doesn't trade off some of its high expected ROE for more sustainable organic growth by writing business at a slightly worse combined ratio, given that growth is a key focus.

    Answer

    Thomas Wilson (executive) responded directly, stating, 'we think can do both.' He explained that Allstate has historically operated with a superior combined ratio while remaining competitive and pointed to a competitor that successfully achieves both strong growth and profitability. Wilson believes executing on growth is the primary way to unlock a higher valuation multiple for the company.

    Ask Fintool Equity Research AI

    Mike Zaremski's questions to TWFG (TWFG) leadership

    Mike Zaremski's questions to TWFG (TWFG) leadership • Q4 2024

    Question

    Representing Mike Zaremski of BMO Capital Markets, Charlie asked about the key variables behind the wide 11-16% organic growth guidance for 2025. He also sought clarification on the impact of delayed public company costs on the EBITDA margin outlook, the nature of contingent commission calculations, and the expected timeline for new agent consolidation.

    Answer

    Executive Richard Bunch explained the organic growth range is influenced by potential rate volatility in auto insurance and capacity constraints in property markets like California. For EBITDA margins, he noted 2024 only included half a year of public company costs and that the 2025 guidance is conservative, not fully factoring in potentially higher contingent commissions. He detailed that contingent commission calculations are complex and vary by carrier, making them hard to forecast. Finally, he anticipates new agent consolidation will largely resolve during 2025.

    Ask Fintool Equity Research AI

    Mike Zaremski's questions to Chubb (CB) leadership

    Mike Zaremski's questions to Chubb (CB) leadership • Q3 2024

    Question

    Mike Zaremski of BMO Capital Markets questioned why casualty pricing was accelerating to 12% if loss costs are well below that level and attempted to ask about future guidance for the Life Insurance business.

    Answer

    Chairman and CEO Evan G. Greenberg explained that the 12% pricing increase is a blended result across a diverse portfolio; while most of the book is adequately priced, certain areas require accelerated rates to achieve adequacy. He cut off the second question, reiterating that his comment on the 2024 life income target was a one-time clarification and not a precedent for future guidance.

    Ask Fintool Equity Research AI